RE:RE:RE:RE:RE:RE:RE: Boehringer Ingelheim Fossi, thanks for joining in the conversation here. Some of us are truly excited about the prospects for the company. The work by Dr.Ask with BI highlighted by Proph helps us understand Ceapros direction for the pre clinical studies and strong candidates for potential partners. Now we are eagerly awaiting some study results.